Information Provided By:
Fly News Breaks for January 2, 2020
EW
Jan 2, 2020 | 06:58 EDT
Evercore ISI analyst Vijay Kumar downgraded Edwards Lifesciences to In Line from Outperform with a $324 price target. The analyst thinks expectations are high and does not see any major clinical catalysts in 2020.